Drug Repurposing for Inclusion of COVID-19-Related Indication: Field Study of the European Medicines Agency’s Response to the Pandemic
As one of the biggest challenges for healthcare in the 21st century, COVID-19 placed a sustained and intense demand on the European Medicines Agency’s resources and required constant adaptation and mobilization of different regulatory processes. In this situation, drug repurposing appeared as a prom...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
MDPI AG
2025-12-01
|
| Serie: | Pharmacy |
| Soggetti: | |
| Accesso online: | https://www.mdpi.com/2226-4787/13/6/179 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|